ACR24 - Day2a
Rheumnow Podcast
00:00
Exploring Gender Differences and Metabolic Correlations in Rheumatoid Arthritis Treatments
This chapter explores findings from two studies presented at ACR 2024 regarding sex-related disparities in treatment responses to biologics in ankylosing spondylitis and the impact of serum adipokines on prognosis in rheumatoid arthritis-related interstitial lung disease. It highlights higher efficacy response rates in male patients and identifies fibroblast growth factor 21 as a critical prognostic marker for managing RA-ILD complications.
Transcript
Play full episode
